These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11193576)

  • 21. Apoptosis and intestinal barrier function.
    Bojarski C; Bendfeldt K; Gitter AH; Mankertz J; Fromm M; Wagner S; Riecken EO; Schulzke JD
    Ann N Y Acad Sci; 2000; 915():270-4. PubMed ID: 11193586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lactoferrin protects against intestinal inflammation and bacteria-induced barrier dysfunction in vitro.
    Hering NA; Luettig J; Krug SM; Wiegand S; Gross G; van Tol EA; Schulzke JD; Rosenthal R
    Ann N Y Acad Sci; 2017 Oct; 1405(1):177-188. PubMed ID: 28614589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation.
    Ma TY; Iwamoto GK; Hoa NT; Akotia V; Pedram A; Boivin MA; Said HM
    Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G367-76. PubMed ID: 14766535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Berberine attenuates pro-inflammatory cytokine-induced tight junction disruption in an in vitro model of intestinal epithelial cells.
    Li N; Gu L; Qu L; Gong J; Li Q; Zhu W; Li J
    Eur J Pharm Sci; 2010 Apr; 40(1):1-8. PubMed ID: 20149867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of muscarinic cholinoceptor ameliorates tumor necrosis factor-α-induced barrier dysfunction in intestinal epithelial cells.
    Khan MR; Uwada J; Yazawa T; Islam MT; Krug SM; Fromm M; Karaki S; Suzuki Y; Kuwahara A; Yoshiki H; Sada K; Muramatsu I; Anisuzzaman AS; Taniguchi T
    FEBS Lett; 2015 Nov; 589(23):3640-7. PubMed ID: 26519558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methamphetamine-induced alterations in intestinal mucosal barrier function occur via the microRNA-181c/ TNF-α/tight junction axis.
    Shen S; Zhao J; Dai Y; Chen F; Zhang Z; Yu J; Wang K
    Toxicol Lett; 2020 Mar; 321():73-82. PubMed ID: 31862507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AMP-18 protects barrier function of colonic epithelial cells: role of tight junction proteins.
    Walsh-Reitz MM; Huang EF; Musch MW; Chang EB; Martin TE; Kartha S; Toback FG
    Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G163-71. PubMed ID: 15961882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential Regulatory Effects of Corticotropin-Releasing Factor on Tight Junction-Related Intestinal Epithelial Permeability are Partially Mediated by CK8 Upregulation.
    Yue H; Bin L; Chaoying C; Meng Z; Meng L; Xi W
    Cell Physiol Biochem; 2017; 44(3):1161-1173. PubMed ID: 29179184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of glucocorticoid regulation of the intestinal tight junction barrier.
    Boivin MA; Ye D; Kennedy JC; Al-Sadi R; Shepela C; Ma TY
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G590-8. PubMed ID: 17068119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of CRF2 signaling in enterocyte differentiation.
    Ducarouge B; Pelissier-Rota M; Powell R; Buisson A; Bonaz B; Jacquier-Sarlin M
    World J Gastroenterol; 2017 Jul; 23(28):5127-5145. PubMed ID: 28811708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier.
    Moran GW; O'Neill C; McLaughlin JT
    Regul Pept; 2012 Oct; 178(1-3):95-101. PubMed ID: 22809889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Culture of Intestinal Epithelial Cell Monolayers and Their Use in Multiplex Macromolecular Permeability Assays for In Vitro Analysis of Tight Junction Size Selectivity.
    Pongkorpsakol P; Turner JR; Zuo L
    Curr Protoc Immunol; 2020 Dec; 131(1):e112. PubMed ID: 33175441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of hypoxia-inducible factor-1α by YC-1 attenuates interferon-γ and tumor necrosis factor-α-induced intestinal epithelial barrier dysfunction.
    Liu H; Li M; Wang P; Wang F
    Cytokine; 2011 Dec; 56(3):581-8. PubMed ID: 21890376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells.
    Fischer A; Gluth M; Pape UF; Wiedenmann B; Theuring F; Baumgart DC
    Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G970-9. PubMed ID: 23538493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bryostatin-1 attenuates TNF-induced epithelial barrier dysfunction: role of novel PKC isozymes.
    Yoo J; Nichols A; Song JC; Mammen J; Calvo I; Worrell RT; Cuppoletti J; Matlin K; Matthews JB
    Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G703-12. PubMed ID: 12505880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of airway tight junctions by proinflammatory cytokines.
    Coyne CB; Vanhook MK; Gambling TM; Carson JL; Boucher RC; Johnson LG
    Mol Biol Cell; 2002 Sep; 13(9):3218-34. PubMed ID: 12221127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Colon Epithelia, Clostridium perfringens Enterotoxin Causes Focal Leaks by Targeting Claudins Which are Apically Accessible Due to Tight Junction Derangement.
    Eichner M; Augustin C; Fromm A; Piontek A; Walther W; Bücker R; Fromm M; Krause G; Schulzke JD; Günzel D; Piontek J
    J Infect Dis; 2017 Dec; 217(1):147-157. PubMed ID: 28968861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased epithelial permeability is the primary cause for bicarbonate loss in inflamed murine colon.
    Juric M; Xiao F; Amasheh S; May O; Wahl K; Bantel H; Manns MP; Seidler U; Bachmann O
    Inflamm Bowel Dis; 2013 Apr; 19(5):904-11. PubMed ID: 23502355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocorticoids regulate barrier function and claudin expression in intestinal epithelial cells via MKP-1.
    Fischer A; Gluth M; Weege F; Pape UF; Wiedenmann B; Baumgart DC; Theuring F
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G218-28. PubMed ID: 24309183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oregonin inhibits inflammation and protects against barrier disruption in intestinal epithelial cells.
    Chi JH; Seo GS; Lee SH
    Int Immunopharmacol; 2018 Jun; 59():134-140. PubMed ID: 29655054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.